Home / Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial unknow ★ 5.0 · 55 reads Sign in to save this Request CodeZLIB.IO18490946 Published2022 Pages1 LanguageUnknown